Search results
Results from the WOW.Com Content Network
SIADH is less common than appropriate release of ADH. While it should be considered in a differential, other causes should be considered as well. [15] Cerebral salt wasting syndrome (CSWS) also presents with hyponatremia, there are signs of dehydration for which reason the management is diametrically opposed to SIADH. Importantly CSWS can be ...
Cerebral salt-wasting syndrome (CSWS), also written cerebral salt wasting syndrome, is a rare endocrine condition featuring a low blood sodium concentration and dehydration in response to injury (trauma) or the presence of tumors in or surrounding the brain. In this condition, the kidney is functioning normally but excreting excessive sodium. [1]
Main page; Contents; Current events; Random article; About Wikipedia; Contact us
contingency management (in which people are paid for improving health behaviors) found that the single most important determinant of effect size was whether behavior-contingent rewards were delivered immediately or only after a time delay (Jennifer P. Lussier et al. 2006).
Hypoosmolar hyponatremia is a condition where hyponatremia is associated with a low plasma osmolality. [1] The term "hypotonic hyponatremia" is also sometimes used.[2]When the plasma osmolarity is low, the extracellular fluid volume status may be in one of three states: low volume, normal volume, or high volume.
This page was last edited on 5 September 2012, at 20:45 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
Primary polydipsia and psychogenic polydipsia are forms of polydipsia [1] characterised by excessive fluid intake in the absence of physiological stimuli to drink. [2] Psychogenic polydipsia caused by psychiatric disorders—oftentimes schizophrenia —is frequently accompanied by the sensation of dry mouth .
The "vaptan" drugs act by directly blocking the action of vasopressin at its receptors (V 1A, V 1B and V 2).These receptors have a variety of functions, with the V 1A and V 2 receptors are expressed peripherally and involved in the modulation of blood pressure and kidney function respectively, while the V 1A and V 1B receptors are expressed in the central nervous system.